Cargando…

Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation

Proliferative diabetic retinopathy (PDR) the sequel of diabetic retinopathy (DR), a frequent complication of diabetes mellitus (DM), is the leading cause of blindness in the working-age population. The current screening process for the DR risk is not sufficiently effective such that often the diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kropp, Martina, Golubnitschaja, Olga, Mazurakova, Alena, Koklesova, Lenka, Sargheini, Nafiseh, Vo, Trong-Tin Kevin Steve, de Clerck, Eline, Polivka, Jiri, Potuznik, Pavel, Stetkarova, Ivana, Kubatka, Peter, Thumann, Gabriele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971534/ https://www.ncbi.nlm.nih.gov/pubmed/36866156 http://dx.doi.org/10.1007/s13167-023-00314-8

Ejemplares similares

Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach
por: Golubnitschaja, Olga, et al.
Publicado: (2022)

Short communication: unique metabolic signature of proliferative retinopathy in the tear fluid of diabetic patients with comorbidities — preliminary data for PPPM validation
por: Kropp, Martina, et al.
Publicado: (2023)

Mitochondrial health quality control: measurements and interpretation in the framework of predictive, preventive, and personalized medicine
por: Koklesova, Lenka, et al.
Publicado: (2022)

Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells
por: Mazurakova, Alena, et al.
Publicado: (2023)

Mitochondriopathies as a Clue to Systemic Disorders—Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine
por: Liskova, Alena, et al.
Publicado: (2021)

Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person
por: Koklesova, Lenka, et al.
Publicado: (2021)

Flavonoids Synergistically Enhance the Anti-Glioblastoma Effects of Chemotherapeutic Drugs
por: Zhai, Kevin, et al.
Publicado: (2021)

Pre-pregnancy check-up of maternal vascular status and associated phenotype is crucial for the health of mother and offspring
por: Evsevieva, Maria, et al.
Publicado: (2022)

Caution, “normal” BMI: health risks associated with potentially masked individual underweight—EPMA Position Paper 2021
por: Golubnitschaja, Olga, et al.
Publicado: (2021)

Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine — comprehensive effects of phytochemicals in primary, secondary and tertiary care
por: Mazurakova, Alena, et al.
Publicado: (2022)

Liquid Biopsy is Instrumental for 3PM Dimensional Solutions in Cancer Management
por: Liskova, Alena, et al.
Publicado: (2020)

Phytochemical-based nanodrugs going beyond the state-of-the-art in cancer management—Targeting cancer stem cells in the framework of predictive, preventive, personalized medicine
por: Koklesova, Lenka, et al.
Publicado: (2023)

“Pre-metastatic niches” in breast cancer: are they created by or prior to the tumour onset? “Flammer Syndrome” relevance to address the question
por: Bubnov, Rostyslav, et al.
Publicado: (2017)

Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope?
por: Crigna, Adriana Torres, et al.
Publicado: (2020)

Personalized approach to primary and secondary prevention of ischemic stroke
por: Polívka, Jiří, et al.
Publicado: (2014)

Pre-graduate and post-graduate education in personalized medicine in the Czech Republic: statistics, analysis and recommendations
por: Polivka, Jiri, et al.
Publicado: (2014)

The application of personalized medicine in neurooncology
por: Polivka Jr, Jiri, et al.
Publicado: (2014)

Antithrombotic and antiplatelet effects of plant-derived compounds: a great utility potential for primary, secondary, and tertiary care in the framework of 3P medicine
por: Kubatka, Peter, et al.
Publicado: (2022)

Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways
por: Kubatka, Peter, et al.
Publicado: (2021)

Current status of biomarker research in neurology
por: Polivka, Jiri, et al.
Publicado: (2016)

Stroke care in West Bohemia – personalised medicine approach
por: Polivka, Jiri, et al.
Publicado: (2014)

Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects—the evidence-based 3PM proposition to mitigate individual risks
por: Liskova, Alena, et al.
Publicado: (2021)

Voice perturbations under the stress overload in young individuals: phenotyping and suboptimal health as predictors for cascading pathologies
por: Kunin, A., et al.
Publicado: (2020)

Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine
por: Kapinova, Andrea, et al.
Publicado: (2023)

The activities of the young professionals EPMA in the Czech Republic
por: Polivka Jr , Jiri, et al.
Publicado: (2014)

Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care
por: Mazurakova, Alena, et al.
Publicado: (2022)

IDH1 mutation is associated with lower expression of VEGF but not microvessel formation in glioblastoma multiforme
por: Polívka, Jiří, et al.
Publicado: (2018)

Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper
por: Golubnitschaja, Olga, et al.
Publicado: (2022)

Education in personalized medicine in Czech Republic
por: Karlikova, Marie, et al.
Publicado: (2014)

Insights into Antiviral Properties and Molecular Mechanisms of Non-Flavonoid Polyphenols against Human Herpesviruses
por: Hassan, Sherif T. S., et al.
Publicado: (2022)

Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
por: Samuel, Samson Mathews, et al.
Publicado: (2020)

It’s the Little Things (in Viral RNA)
por: Potužník, Jiří František, et al.
Publicado: (2020)

Flavonoids’ Dual Benefits in Gastrointestinal Cancer and Diabetes: A Potential Treatment on the Horizon?
por: AL-Ishaq, Raghad Khalid, et al.
Publicado: (2022)

Carotenoids in Cancer Apoptosis—The Road from Bench to Bedside and Back
por: Koklesova, Lenka, et al.
Publicado: (2020)

Carotenoids in Cancer Metastasis—Status Quo and Outlook
por: Koklesova, Lenka, et al.
Publicado: (2020)

Bowman Layer Transplantation for Treating Keratoconus—Preliminary Findings
por: De Clerck, Eline Elodie Barbara, et al.
Publicado: (2023)

Immunomodulation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer
por: AL-Ishaq, Raghad Khalid, et al.
Publicado: (2022)

Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine
por: Koklesova, Lenka, et al.
Publicado: (2021)

Comparison of Conventional and Femtosecond Laser-Assisted Cataract Surgery Regarding Macula Behavior and Thickness
por: Slezak, Filip, et al.
Publicado: (2023)

Rho GTPases in Gynecologic Cancers: In-Depth Analysis toward the Paradigm Change from Reactive to Predictive, Preventive, and Personalized Medical Approach Benefiting the Patient and Healthcare
por: Zubor, Pavol, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e5g2gljf47rk0md1goao0fja6k